Retraction: MicroRNA-153-3p sensitizes melanoma cells to dacarbazine by suppressing ATG5-mediated autophagy and apoptosis
Retraction

Retraction: MicroRNA-153-3p sensitizes melanoma cells to dacarbazine by suppressing ATG5-mediated autophagy and apoptosis

Shaowei Hou1, Minfang Guo1, Haiying Xi2, Lianqing Zhang2, Ailing Zhao3, Heng Hou1, Wuning Fang4

1Medical College of Shanxi Datong University, Datong, China; 2Department of Dermatological, The Fifth People’s Hospital of Datong, Datong, China; 3Department of Neurology, The Fifth People’s Hospital of Datong, Datong, China; 4Department of Dermatology, Xi’an International Medical Center Hospital, Xi’an, China

Correspondence to: Wuning Fang. Department of Dermatology, Xi’an International Medical Center Hospital, No. 777 Xitai Road, High-tech District, Xi’an 710100, China. Email: aetw1aqav6kx@sina.com.

Submitted Nov 05, 2024. Accepted for publication Nov 29, 2024. Published online Jan 23, 2025.

doi: 10.21037/tcr-2024B-11


Retraction to: Transl Cancer Res 2020;9:5626-36.

We request the retraction of our article entitled “MicroRNA-153-3p sensitizes melanoma cells to dacarbazine by suppressing ATG5-mediated autophagy and apoptosis” (1), which was published in Vol 9, No 9 (September 24, 2020) issue of Translational Cancer Research (TCR).

The primary reason for this retraction is that we recently discovered that the cell lines used in our experiments were contaminated, which compromised the validity of our data. Despite our rigorous efforts to ensure data accuracy, this contamination may have impacted the reliability of the experimental results and the conclusions drawn from them. To uphold the standards of scientific integrity, we believe that retracting the paper is the most responsible course of action.

We apologize for any inconvenience this may cause to the journal and its readers, and we regret any potential misunderstanding that our findings may have created. We are committed to implementing stricter quality control measures to prevent similar issues in future research.


Footnote

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tcr.amegroups.com/article/view/10.21037/tcr-2024B-11/coif). The authors have no conflicts of interest to declare.

Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.


References

  1. Hou S, Guo M, Xi H, et al. MicroRNA-153-3p sensitizes melanoma cells to dacarbazine by suppressing ATG5-mediated autophagy and apoptosis. Transl Cancer Res 2020;9:5626-36. [Crossref] [PubMed]
Cite this article as: Hou S, Guo M, Xi H, Zhang L, Zhao A, Hou H, Fang W. Retraction: MicroRNA-153-3p sensitizes melanoma cells to dacarbazine by suppressing ATG5-mediated autophagy and apoptosis. Transl Cancer Res 2025;14(1):658-659. doi: 10.21037/tcr-2024B-11

Download Citation